Skip to content

Health Network One and Premier Eye Care are now Emboss Specialty! | View Press Release | View FAQs

    Contact us

    Health Network One is now Emboss Specialty! | View Press Release | View FAQs

      Contact Us
      Pure Derm

      A Clearer Path to Dermatology Savings

      Pure Derm delivers up to 25% savings through value-based reimbursement, treatment pathway management, and specialty pharmacy oversight.

      Dermatology Spend Starts Long Before Claims Become Costly

      Dermatology is a growing driver of both medical and pharmacy spend for health plans. From skin cancer surveillance and procedural care to chronic conditions such as psoriasis and eczema, the decisions made throughout the care journey can have a significant impact on outcomes and cost.

      Health plans face a common challenge: ensuring members receive timely care, appropriate treatment, and consistent follow-up while managing rising specialty utilization and pharmacy expenses. When care gaps or treatment pathways vary significantly, costs escalate and plans have less visibility into the care decisions driving them.

      Pure Derm helps health plans take a more proactive approach to dermatology management through clinical guidance, provider accountability, specialty pharmacy stewardship, and targeted programs designed to improve outcomes while managing total cost of care.

      6.1M Adults Treated for Skin Cancer Annually

      Skin cancer remains the most common cancer diagnosis in the United States and a major source of specialty utilization. 

      Follow-Up Gaps Increase Long-Term Risk

      Members diagnosed with skin cancer require ongoing surveillance and follow-up to support earlier identification of recurrence and progression.

      Advanced Therapies Average $40K PMPY

      Psoriasis and eczema treatment can create significant specialty pharmacy exposure, with some biologics costing up to $95,000 per member per year. 

      UVB Therapy is Often Underutilized

      Guideline-supported phototherapy is frequently bypassed despite its role in treatment pathways that precede advanced therapies. 

      Sources:
      American Academy of Dermatology Association. Skin Cancer.
      Guy GP Jr., Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and Costs of Skin Cancer Treatment in the U.S., 2002-2006 and 2007-2011. American Journal of Preventive Medicine. 2015.
      American Academy of Dermatology Association. Guidelines of Care for the Management and Treatment of Psoriasis with Phototherapy.
      National Psoriasis Foundation. Treatment Targets for Plaque Psoriasis.
      American Academy of Dermatology Association. Atopic Dermatitis Clinical Guideline.

      A Proactive Model for Managing Dermatology Risk

      Pure Derm helps health plans identify care gaps, reduce unnecessary variation, and create greater accountability across dermatology care. By combining provider engagement, clinical guidance, treatment pathway management, and specialty pharmacy stewardship, Pure Derm addresses the factors that most directly influence outcomes and spend.

      Icon_Presenter With Analytics Board

      Data-Driven
      Intelligence

       Claims-based insights help identify care gaps, treatment variation, high-cost utilization patterns, and opportunities for earlier intervention.  

      Icon_Male Provider 2

      Provider Accountability

       Value-based reimbursement aligns incentives around quality, outcomes, access, and cost management.  

      Icon_Team Collaboration Settings

      Treatment Pathway Management

       Clinical guidance promotes evidence-based treatment decisions and more consistent dermatology care across providers and treatment settings.  

      Icon_Financial Search Network

      Specialty Pharmacy Stewardship

       Targeted programs and guideline-supported pathways help manage biologic utilization while supporting appropriate care.  

      Pure Derm In Action

      Melanoma Follow-Up Program

      Members diagnosed with melanoma face ongoing risk of recurrence and progression without timely follow-up care. Pure Derm uses claims-based monitoring and targeted outreach to help health plans identify members who may be overdue for recommended surveillance, supporting earlier intervention, continuity of care, and reduced downstream costs associated with delayed detection. 

      iStock-2227521767_healthcare_male_patient_dermatology_skin check

      Clear Skin: A Better Pathway for Psoriasis and Eczema Care

      Clear Skin extends the Pure Derm model into one of the fastest-growing areas of specialty spend. Designed for members with psoriasis and eczema, the program improves access to guideline-supported UVB phototherapy before progression to high-cost advanced therapies.

      For many health plans, rising dermatology drug costs are being fueled by increasing utilization of biologics and biosimilars. Despite being a recommended step in the treatment pathway, UVB phototherapy is frequently bypassed due to limited access, provider burden, and the challenges associated with traditional phototherapy delivery.

      Powered in collaboration with Zerigo Health, Clear Skin is a value-based dermatology program designed to improve access to guideline-supported treatment for psoriasis and eczema. Through in-home UVB phototherapy, provider engagement, and ongoing clinical support, the program removes those barriers and helps members access appropriate therapy earlier while avoiding higher cost biologics.

      Female_Light-Device_Ktichen_0744_smaller

      Results That Matter

      $10K+ PMPY

      Savings for Identified Members

      2:1

      Guaranteed
      ROI 

      80%

      Clinical Improvement
      at 12 Weeks

      75%

      Member Adherence

      Let's Make a Mark in Specialty Management

      Pure Derm helps health plans improve outcomes, close care gaps, and manage the clinical and pharmacy drivers of dermatology spend through a more accountable approach to specialty care.

      Download Pure Derm Overview